Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.
Wittig B, Märten A, Dorbic T, Weineck S, Min H, Niemitz S, Trojaneck B, Flieger D, Kruopis S, Albers A, Löffel J, Neubauer A, Albers P, Müller S, Sauerbruch T, Bieber T, Huhn D, Schmidt-Wolf IG. Wittig B, et al. Hum Gene Ther. 2001 Feb 10;12(3):267-78. doi: 10.1089/10430340150218404. Hum Gene Ther. 2001. PMID: 11177563 Clinical Trial.
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial.
Märten A, Flieger D, Renoth S, Weineck S, Albers P, Compes M, Schöttker B, Ziske C, Engelhart S, Hanfland P, Krizek L, Faber C, von Ruecker A, Müller S, Sauerbruch T, Schmidt-Wolf IG. Märten A, et al. Cancer Immunol Immunother. 2002 Dec;51(11-12):637-44. doi: 10.1007/s00262-002-0324-0. Epub 2002 Oct 3. Cancer Immunol Immunother. 2002. PMID: 12439609 Free PMC article. Clinical Trial.
Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
Märten A, Renoth S, Heinicke T, Albers P, Pauli A, Mey U, Caspari R, Flieger D, Hanfland P, Von Ruecker A, Eis-Hübinger AM, Müller S, Schwaner I, Lohmann U, Heylmann G, Sauerbruch T, Schmidt-Wolf IG. Märten A, et al. Hum Gene Ther. 2003 Mar 20;14(5):483-94. doi: 10.1089/104303403321467243. Hum Gene Ther. 2003. PMID: 12691613 Clinical Trial.
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
González-Carmona MA, Märten A, Hoffmann P, Schneider C, Sievers E, Schmidt-Wolf IG, Sauerbruch T, Caselmann WH. González-Carmona MA, et al. Liver Int. 2006 Apr;26(3):369-79. doi: 10.1111/j.1478-3231.2005.01235.x. Liver Int. 2006. PMID: 16584401
Characterization of primary renal carcinoma cultures.
Sievers E, Dreimuller P, Haferkamp A, Schmidt-Wolf IG, Buchler MW, Schmidt J, Marten A. Sievers E, et al. Urol Int. 2007;79(3):235-43. doi: 10.1159/000107956. Urol Int. 2007. PMID: 17940356
338 results